Categories for Immuno-oncology

Oncimmune to participate at the ASCO 2023 Meeting

April 28, 2023 3:04 pm

Oncimmune signs contracts with US-based clinical-stage biopharmaceutical companies developing immunotherapies one of which is focused on CAR NK cell therapies.

April 8, 2022 9:06 am

Ground-breaking blood test could reduce lung cancer deaths

September 9, 2019 11:45 am

Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events

June 14, 2018 4:14 pm